$1.320
-0.029 (-2.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
INM Prediction & Forecast by Similar Chart Analysis
Alphio's INM stock price prediction model matches the current InMed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.32 (-0.25%). The 1-week path is $1.25 (-5.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy InMed Pharmaceuticals Inc Stock?
InMed Pharmaceuticals is not a good buy right now due to its low RSI of 31.092, indicating oversold conditions, and a significant 1-year change of -36.11%. While the recent merger news may provide some potential upside, the current financial performance shows a troubling trend with a net income loss of -2,966,336 USD in Q3 2026 and a gross margin drop to 15.97% in Q2 2026, which raises concerns about its profitability and sustainability.
INM stock price ended at $1.32 on Tuesday, after losing -2.22%
InMed Pharmaceuticals Inc (INM) last closed at $1.32, losing -2.22%. These facts feed the 1-day and 1-week INM price prediction above.
Forecast Drivers
InMed Pharmaceuticals Inc (INM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches INM, ranked by similarity.
Seasonality analysis for INM
Historically the probability of a positive September return for INM is 2.38%. August offers the highest probability of a positive month at 40.62%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.